Staffing shortages frustrate leaders at many research centers, both academic and community settings. In this episode, Dr. Daniel Flora discusses the many challenges of conducting research and his team's exploration of AI and outsourcing solutions to help screen cancer patients for trials. A Medical Oncologist at St. Elizabeth Healthcare in Kentucky, Dr. Flora also leads an ACCRU Phase 2 study to test a novel SERM in premenopausal, ER Positive breast cancer patients. With a background in pharmacology, Dr. Flora has a special interest in “personalized medicine,” in which each individual’s treatment plan is developed to minimize toxicity.